Effects of Dapagliflozin and/or Insulin Glargine on Hepatic Steatosis in db/db Mice

被引：0
|
作者：
Omori, Kazuno
Nakamura, Akinobu
Miyoshi, Hideaki
Nomoto, Hiroshi
Kameda, Hiraku
Cho, Kyuyong
Terauchi, Yasuo
Atsumi, Tatsuya
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1855-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1855-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] C-C chemokine receptor-2 inhibitor ameliorates insulin resistance and hepatic steatosis in db/db mice.
    Tamura, Yukinori
    Arai, Hidenon
    Sugimoto, Masayuki
    Murayama, Toshinori
    Ueda, Yukihiko
    Kanamori, Hiroshi
    Ono, Koh
    Ariyasu, Hiroyuki
    Akamizu, Takashi
    Kita, Toru
    Yokode, Masayuki
    [J]. CIRCULATION, 2007, 116 (16) : 170 - 170
  • [22] Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice
    Kong, Qin
    Zhang, Haojun
    Zhao, Tingting
    Zhang, Weiku
    Yan, Meihua
    Dong, Xi
    Li, Ping
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (06) : 1715 - 1726
  • [23] Ezetimibe Ameliorates Cardiovascular Complications and Hepatic Steatosis in Obese and Type 2 Diabetic db/db Mice
    Fukuda, Masaya
    Nakamura, Taishi
    Kataoka, Keiichiro
    Nako, Hisato
    Tokutomi, Yoshiko
    Dong, Yi-Fei
    Yasuda, Osamu
    Ogawa, Hisao
    Kim-Mitsuyama, Shokei
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (01): : 70 - 75
  • [24] Molecular insights of liver steatosis and inflammation in db/db mice
    Scheerer, M. F.
    Fridrich, B.
    Kastenmueller, G.
    Irmler, M.
    Kahle, M.
    Beckers, J.
    Suhre, K.
    Mewes, H. -W.
    de Angelis, M. Hrabe
    Neschen, S.
    [J]. DIABETOLOGIA, 2012, 55 : S262 - S262
  • [25] Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
    Zhai, Mingming
    Yan, Xi
    Liu, Jiangzheng
    Long, Zi
    Zhao, Siyan
    Li, Wendan
    Liu, Ying
    Hai, Chunxu
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1035 - 1042
  • [26] Overexpression of the Lias gene attenuates hepatic steatosis in Leprdb/db mice
    Xu, Guangcui
    Yan, Tingting
    Peng, Qiang
    Li, Haibin
    Wu, Weidong
    Yi, Xianwen
    Zhao, Yingzheng
    [J]. JOURNAL OF ENDOCRINOLOGY, 2021, 248 (02) : 119 - 131
  • [27] Dietary Supplement of Large Yellow Tea Ameliorates Metabolic Syndrome and Attenuates Hepatic Steatosis in db/db Mice
    Teng, Yun
    Li, Daxiang
    Guruvaiah, Ponmari
    Xu, Na
    Xie, Zhongwen
    [J]. NUTRIENTS, 2018, 10 (01)
  • [28] Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice
    Jia, Yingli
    He, Jinzhao
    Wang, Liang
    Su, Limin
    Lei, Lei
    Huang, Wei
    Geng, Xiaoqiang
    Zhang, Shun
    Meng, Xiaolu
    Zhou, Hong
    Yang, Baoxue
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (05) : 1747 - 1758
  • [29] Supression of hepatic Foxo1 function improves insulin sensitivity in db/db mice
    Richter, A
    Altomonte, J
    Harbaran, S
    Meseck, M
    Accili, D
    Dong, HJ
    [J]. DIABETES, 2003, 52 : A68 - A69
  • [30] Effect of alogliptin, pioglitazone and glargine on pancreatic β-cells in diabetic db/db mice
    Kawashima, Satoshi
    Matsuoka, Taka-aki
    Kaneto, Hideaki
    Tochino, Yoshihiro
    Kato, Ken
    Yamamoto, Kaoru
    Yamamoto, Tsunehiko
    Matsuhisa, Munehide
    Shimomura, Iichiro
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 404 (01) : 534 - 540
12345